These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytokine induction and modifying the immune response to human papilloma virus with imiquimod. Slade HB Eur J Dermatol; 1998; 8(7 Suppl):13-6; discussion 20-2. PubMed ID: 10387958 [TBL] [Abstract][Full Text] [Related]
3. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906 [TBL] [Abstract][Full Text] [Related]
4. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study. Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Arany I; Tyring SK; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB Antiviral Res; 1999 Aug; 43(1):55-63. PubMed ID: 10480263 [TBL] [Abstract][Full Text] [Related]
9. Topical imiquimod: a review of its use in genital warts. Perry CM; Lamb HM Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026 [TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742 [TBL] [Abstract][Full Text] [Related]
11. Imiquimod; an international update on therapeutic uses in dermatology. Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012 [TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sauder DN; Skinner RB; Fox TL; Owens ML Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169 [TBL] [Abstract][Full Text] [Related]
14. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784 [TBL] [Abstract][Full Text] [Related]
15. Imiquimod: a review. Gupta AK; Browne M; Bluhm R J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256 [TBL] [Abstract][Full Text] [Related]
16. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study. Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759 [TBL] [Abstract][Full Text] [Related]